Asensus Surgical Inc (AMEX: ASXC) closed the day trading at $0.31 up 7.09% from the previous closing price of $0.28. In other words, the price has increased by $+0.0202 from its previous closing price. On the day, 598897 shares were traded. ASXC stock price reached its highest trading level at $0.3052 during the session, while it also had its lowest trading level at $0.2851.
Ratios:
For a better understanding of ASXC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.24 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $1.50.
On May 26, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on May 26, 2021, with a $4 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 14 when Starling William N JR bought 18,134 shares for $0.28 per share. The transaction valued at 5,078 led to the insider holds 39,134 shares of the business.
Starling William N JR sold 18,134 shares of ASXC for $5,078 on Dec 14. The Director now owns 0 shares after completing the transaction at $0.28 per share. On Mar 03, another insider, Biffi Andrea, who serves as the Director of the company, bought 293,077 shares for $0.71 each. As a result, the insider paid 207,557 and bolstered with 492,815 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 80.85M and an Enterprise Value of 53.25M. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.38 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 9.49 whereas that against EBITDA is -0.71.
Stock Price History:
Over the past 52 weeks, ASXC has reached a high of $0.96, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 0.2990, while the 200-Day Moving Average is calculated to be 0.3517.
Shares Statistics:
Over the past 3-months, ASXC traded about 1.27M shares per day on average, while over the past 10 days, ASXC traded about 909.98k shares per day. A total of 264.32M shares are outstanding, with a floating share count of 259.00M. Insiders hold about 2.01% of the company’s shares, while institutions hold 10.03% stake in the company. Shares short for ASXC as of Jan 31, 2024 were 17.51M with a Short Ratio of 13.78, compared to 19.61M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 6.61% and a Short% of Float of 6.72%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.08, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.19, with 1 analysts recommending between -$0.19 and -$0.19.
Revenue Estimates
1 analysts predict $5.3M in revenue for the current quarter. It ranges from a high estimate of $5.3M to a low estimate of $5.3M. As of the current estimate, Asensus Surgical Inc’s year-ago sales were $2.46M, an estimated increase of 115.10% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $1.5M, an increase of 53.70% less than the figure of $115.10% in the same quarter last year. There is a high estimate of $1.5M for the next quarter, whereas the lowest estimate is $1.5M.
A total of 1 analysts have provided revenue estimates for ASXC’s current fiscal year. The highest revenue estimate was $8.4M, while the lowest revenue estimate was $8.4M, resulting in an average revenue estimate of $8.4M. In the same quarter a year ago, actual revenue was $7.09M, up 18.50% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $11.8M in the next fiscal year. The high estimate is $11.8M and the low estimate is $11.8M. The average revenue growth estimate for next year is up 40.50% from the average revenue estimate for this year.
